292 related items for PubMed ID: 28224294
1. Cardio-metabolic risk factors in youth with classical 21-hydroxylase deficiency.
Ariyawatkul K, Tepmongkol S, Aroonparkmongkol S, Sahakitrungruang T.
Eur J Pediatr; 2017 Apr; 176(4):537-545. PubMed ID: 28224294
[Abstract] [Full Text] [Related]
2. Obesity among children and adolescents with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Völkl TM, Simm D, Beier C, Dörr HG.
Pediatrics; 2006 Jan; 117(1):e98-105. PubMed ID: 16396852
[Abstract] [Full Text] [Related]
3. Cardiovascular risk, metabolic profile, and body composition in adult males with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Falhammar H, Filipsson Nyström H, Wedell A, Thorén M.
Eur J Endocrinol; 2011 Feb; 164(2):285-93. PubMed ID: 21098686
[Abstract] [Full Text] [Related]
4. Does an altered leptin axis play a role in obesity among children and adolescents with classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency?
Völkl TM, Simm D, Körner A, Rascher W, Kiess W, Kratzsch J, Dörr HG.
Eur J Endocrinol; 2009 Feb; 160(2):239-47. PubMed ID: 19004982
[Abstract] [Full Text] [Related]
5. Metabolic profile and body composition in adult women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Falhammar H, Filipsson H, Holmdahl G, Janson PO, Nordenskjöld A, Hagenfeldt K, Thorén M.
J Clin Endocrinol Metab; 2007 Jan; 92(1):110-6. PubMed ID: 17032717
[Abstract] [Full Text] [Related]
6. Obesity and familial predisposition are significant determining factors of an adverse metabolic profile in young patients with congenital adrenal hyperplasia.
Moreira RP, Villares SM, Madureira G, Mendonca BB, Bachega TA.
Horm Res Paediatr; 2013 Jan; 80(2):111-8. PubMed ID: 23921174
[Abstract] [Full Text] [Related]
7. Increased Abdominal Adiposity in Adolescents and Young Adults With Classical Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency.
Kim MS, Ryabets-Lienhard A, Dao-Tran A, Mittelman SD, Gilsanz V, Schrager SM, Geffner ME.
J Clin Endocrinol Metab; 2015 Aug; 100(8):E1153-9. PubMed ID: 26062016
[Abstract] [Full Text] [Related]
8. Cardiovascular abnormalities and impaired exercise performance in adolescents with congenital adrenal hyperplasia.
Marra AM, Improda N, Capalbo D, Salzano A, Arcopinto M, De Paulis A, Alessio M, Lenzi A, Isidori AM, Cittadini A, Salerno M.
J Clin Endocrinol Metab; 2015 Feb; 100(2):644-52. PubMed ID: 25405496
[Abstract] [Full Text] [Related]
9. Ambulatory blood pressure and subclinical cardiovascular disease in patients with congenital adrenal hyperplasia: a preliminary report.
Akyürek N, Atabek ME, Eklioğlu BS, Alp H.
J Clin Res Pediatr Endocrinol; 2015 Mar; 7(1):13-8. PubMed ID: 25800471
[Abstract] [Full Text] [Related]
10. Cardiovascular and metabolic risk in pediatric patients with congenital adrenal hyperplasia due to 21 hydroxylase deficiency.
Mooij CF, van Herwaarden AE, Sweep FCGJ, Roeleveld N, de Korte CL, Kapusta L, Claahsen-van der Grinten HL.
J Pediatr Endocrinol Metab; 2017 Aug 28; 30(9):957-966. PubMed ID: 28787274
[Abstract] [Full Text] [Related]
11. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency - management in adults.
Ambroziak U, Bednarczuk T, Ginalska-Malinowska M, Małunowicz EM, Grzechocińska B, Kamiński P, Bablok L, Przedlacki J, Bar-Andziak E.
Endokrynol Pol; 2010 Aug 28; 61(1):142-55. PubMed ID: 20205117
[Abstract] [Full Text] [Related]
12. Metabolic profile, cardiovascular risk factors and health-related quality of life in children, adolescents and young adults with congenital adrenal hyperplasia.
Vijayan R, Bhavani N, Pavithran PV, Nair V, Menon UV, Menon AS, Abraham N, Bhadran K, Narayanan P, Kumar H.
J Pediatr Endocrinol Metab; 2019 Aug 27; 32(8):871-877. PubMed ID: 31271560
[Abstract] [Full Text] [Related]
13. Adiponectin levels are high in children with classic congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency.
Völkl TM, Simm D, Körner A, Kiess W, Kratzsch J, Dörr HG.
Acta Paediatr; 2009 May 27; 98(5):885-91. PubMed ID: 19236311
[Abstract] [Full Text] [Related]
14. Health status of adults with congenital adrenal hyperplasia: a cohort study of 203 patients.
Arlt W, Willis DS, Wild SH, Krone N, Doherty EJ, Hahner S, Han TS, Carroll PV, Conway GS, Rees DA, Stimson RH, Walker BR, Connell JM, Ross RJ, United Kingdom Congenital Adrenal Hyperplasia Adult Study Executive (CaHASE).
J Clin Endocrinol Metab; 2010 Nov 27; 95(11):5110-21. PubMed ID: 20719839
[Abstract] [Full Text] [Related]
15. [Congenital adrenal hyperplasia due to 21-hydroxylase deficiency--management in adults].
Ambroziak U, Bednarczuk T, Ginalska-Malinowska M, Małunowicz EM, Grzechocińska B, Kamiński P, Bablok L, Przedlacki J, Bar-Andziak E.
Endokrynol Pol; 2010 Nov 27; 61 Suppl 1():7-21. PubMed ID: 22127631
[Abstract] [Full Text] [Related]
16. Cardiovascular risk factors and ultrasound evaluation of intima-media thickness at common carotids, carotid bulbs, and femoral and abdominal aorta arteries in patients with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Sartorato P, Zulian E, Benedini S, Mariniello B, Schiavi F, Bilora F, Pozzan G, Greggio N, Pagnan A, Mantero F, Scaroni C.
J Clin Endocrinol Metab; 2007 Mar 27; 92(3):1015-8. PubMed ID: 17200174
[Abstract] [Full Text] [Related]
17. Cardiovascular risk in Cuban adolescents and young adults with congenital adrenal hyperplasia.
Espinosa Reyes TM, Pesántez Velepucha AK, Cabrera Rego JO, Valdés Gómez W, Domínguez Alonso E, Falhammar H.
BMC Endocr Disord; 2023 Nov 02; 23(1):241. PubMed ID: 37919699
[Abstract] [Full Text] [Related]
18. Long-Term Health Outcomes of Korean Adults With Classic Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency.
Lim SG, Lee YA, Jang HN, Kong SH, Ahn CH, Kim SW, Shin CH, Kim JH.
Front Endocrinol (Lausanne); 2021 Nov 02; 12():761258. PubMed ID: 34712205
[Abstract] [Full Text] [Related]
19. Cardiovascular risk factors and increased carotid intima-media thickness in young patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Rodrigues TM, Barra CB, Santos JL, Goulart EM, Ferreira AV, Silva IN.
Arch Endocrinol Metab; 2015 Dec 02; 59(6):541-7. PubMed ID: 26677089
[Abstract] [Full Text] [Related]
20. Effect of androgen excess and glucocorticoid exposure on metabolic risk profiles in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Paizoni L, Auer MK, Schmidt H, Hübner A, Bidlingmaier M, Reisch N.
J Steroid Biochem Mol Biol; 2020 Mar 02; 197():105540. PubMed ID: 31730799
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
